Perceptive Advisors »

Dbv Technologies Sa shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 964k 20.89

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Roivant Sciences SHS (ROIV)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Rhythm Pharmaceuticals (RYTM)
Spyre Therapeutics Com New (SYRE)
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Protagonist Therapeutics (PTGX)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Amylyx Pharmaceuticals (AMLX)
Immatics SHS (IMTX)
Relay Therapeutics (RLAY)

View all positions for Perceptive Advisors

Top funds holding Dbv Technologies Sa

MPM Oncology Impact Management
Vivo Capital
Artisan Partners Limited Partnership
Siren
Baker Bros. Advisors
ADAR1 Capital Management
Perceptive Advisors
Patient Square Capital
Octagon Capital Advisors
Ikarian Capital
Redmile Group
Duquesne Family Office
Millennium Management
Atika Capital Management
Elmind Capital

View all funds holding Dbv Technologies Sa